Source: The Daily Beast, by Justin Baragona


Former New York City Mayor Rudy Giuliani on Wednesday revealed that he is currently taking ineffective coronavirus therapeutic hydroxychloroquine in an effort to fend off a possible COVID-19 infection after a slew of Trumpworld figures Giuliani had contact with have fallen ill.

Appearing on Bloomberg TV, the Trump attorney was asked about his recent Fox News interview that featured him heavily coughing as he announced he was waiting on his coronavirus test result. The ex-mayor brushed off the coughing fit as just “clearing my throat” before adding that he has tested negative. “I am not that nervous about it,” Giuliani declared. “I know if it does happen, I know what to take. My doctor has provided hydroxychloroquine, which I’m taking every day.”

After the hosts expressed shock that he was taking the anti-malarial drug that multiple studies have found has little-to-no benefit in preventing or treating coronavirus, Giuliani boasted that his “genius” doctor has treated thousands of COVID-19 patients with the medication and only lost two. While not naming him, it appears Giuliani was referring to Vladimir Zelenko, who previously presented his treatment to the White House and has been interviewed and promoted by Giuliani several times.


New Jersey Study of 1,274: Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19; A multi-center observational study where hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization

Italy Study 3,451 patients: Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

Belgium Study: Low-dose Hydroxychloroquine Therapy and Mortality (Lowered) in Hospitalized Patients with COVID-19: A Nationwide Observational Study of 8075 Participants

China Study of 2882 patients: Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories